2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
W

2020 ASCO Update on Stage III Melanoma: Does Pembrolizumab Improve Recurrence-free Survival After Complete Resection of High-risk Disease?

By 2020 ASCO Virtual Direct™ Highlights FEATURING William Sharfman
By 2020 ASCO Virtual Direct™ Highlights FEATURING William Sharfman
0 views
July 17, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
Skin
06:56
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Stage III Melanoma: Does Pembrolizumab Improve R…

Feat. W. Sharfman
06:53
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resected Stage III BRAF V600-mutant Melanoma: Is…

Feat. W. Sharfman
09:16
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Melanoma: Is There Significant Antitumor Activit…

Feat. W. Sharfman
10:12
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Melanoma: Does Ipilimumab + PD-1 Have a Higher R…

Feat. W. Sharfman
08:08
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Stage IV Melanoma: Is Lifileucel Effective and D…

Feat. W. Sharfman